NASDAQ : GEHC
GE HealthCare Technologies Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 76.57 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 34.62B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 35.96B |
| Enterprise Value | 43.54B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Oct 23, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 452.14M |
| Shares Outstanding | 452.14M |
| Shares Change (YoY) | -0.55% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 0.22% |
| Owned by Institutions (%) | 93.69% |
| Float | 450.65M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 16.81 |
| Forward PE | 14.85 |
| PS Ratio | 1.67 |
| Forward PS | 1.60 |
| PB Ratio | 2.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.11 |
| P/OCF Ratio | 14.95 |
| PEG Ratio | 1.50 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 20.29 |
| EV / Sales | 2.02 |
| EV / EBITDA | 12.15 |
| EV / EBIT | 14.68 |
| EV / FCF | 23.13 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.30 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | 2.71 |
| Debt / FCF | 5.51 |
| Interest Coverage | 7.55 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 20.01% |
| Return on Assets (ROA) | 4.99% |
| Return on Invested Capital (ROIC) | 12.13% |
| Return on Capital Employed (ROCE) | 10.07% |
| Weighted Average Cost of Capital (WACC) | 7.60% |
| Revenue Per Employee | $400,685 |
| Profits Per Employee | $39,870 |
| Employee Count | 54,000 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 5.33 |
Taxes
| Measure | Value |
|---|
| Income Tax | 561.00M |
| Effective Tax Rate | 20.25% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +6.32% |
| 50-Day Moving Average | 68.55 |
| 200-Day Moving Average | 69.81 |
| Relative Strength Index (RSI) | 78.98 |
| Average Volume (20 Days) | 3,777,026 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 19.37M |
| Short Previous Month | 18.52M |
| Short % of Shares Out | 4.29% |
| Short % of Float | 4.30% |
| Short Ratio (days to cover) | 4.91 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 21.64B |
| Gross Profit | 8.50B |
| Operating Income | 2.98B |
| Pretax Income | 2.77B |
| Net Income | 2.15B |
| EBITDA | 3.60B |
| EBIT | 2.98B |
| Earnings Per Share (EPS) | $4.73 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.83B |
| Total Debt | 10.41B |
| Net Cash | -7.58B |
| Net Cash Per Share | -$16.77 |
| Equity (Book Value) | 11.87B |
| Book Value Per Share | 25.69 |
| Working Capital | 2.68B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.42B |
| Capital Expenditures | -526.00M |
| Depreciation & Amortization | 622.00M |
| Net Borrowing | -124.00M |
| Free Cash Flow | 1.89B |
| FCF Per Share | $4.18 |
Margins
| Measure | Value |
|---|
| Gross Margin | 39.28% |
| Operating Margin | 13.75% |
| Pretax Margin | 12.81% |
| Profit Margin | 9.95% |
| EBITDA Margin | 16.62% |
| EBIT Margin | 13.75% |
| FCF Margin | 8.73% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.16 |
| Dividend Yield | 0.20% |
| Dividend Growth (YoY) | 3.57% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 3.38% |
| FCF Payout Ratio | 3.83% |
| Buyback Yield | 0.55% |
| Shareholder Yield | 0.75% |
| Earnings Yield | 5.95% |
| FCF Yield | 5.23% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $87.50 |
| Price Target Difference | 10.01% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 5.23% |
| EPS Growth Forecast (3Y) | 9.71% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.9 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |